Andrea Davila-Ruales
Research Subjects
Andrea Davila-Ruales has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Andrés Felipe Rubio-Duarte
Congenital and Pediatric Heart Diseases Center, Cardiovascular Institute, Hospital Internacional de Colombia HIC—Fundación Cardiovascular de Colombia FCV—Fundación Universitaria FCV, Santander, Colombia
1 shared publication - Claudia Carolina Colmenares Mejía
Fundación Cardiovascular de Colombia
1 shared publication - César Bretón-Pinto
Congenital and Pediatric Heart Diseases Center, Hospital Internacional de Colombia HIC - Fundación Cardiovascular de Colombia FCV - Fundación Universitaria FCV, Santander, Colombia
1 shared publication Eliana Cañas
Cardio VID clinic
1 shared publicationEliana Cañas-Arenas
Department of Epidemiology, Clinica Cardio VID
1 shared publicationGuillermo Aristizabal-Villa
Cardio VID clinic
1 shared publication
Latest Publications
- Open Access
- 11 November 2026
- Published by Elsevier in JACC: Case Reports
- Vol. 31 (45)
Transpulmonary Atrial Pacemaker Implantation in Fontan Circulation With Bilateral Glenn
- 11 November 2026
- Published by Elsevier in JACC: Case Reports
- Vol. 31 (45)
Open AccessTranspulmonary Atrial Pacemaker Implantation in Fontan Circulation With Bilateral Glenn
- 15 October 2026
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- p. 1-12
Short- and long-term outcomes of balloon pulmonary valvuloplasty in children ≤24 months with critical and haemodynamically significant pulmonary valve stenosis: a 20-year single-centre experience in Medellín, Colombia
Background: Balloon pulmonary valvuloplasty is the treatment of choice for critical and haemodynamically significant pulmonary stenosis, but long-term outcome data in infants, particularly in Latin America, remain limited. We evaluated long-term outcomes and factors associated with adverse outcomes in children ≤24 months. Methods: We retrospectively included consecutive patients ≤24 months who underwent balloon pulmonary valvuloplasty for critical or haemodynamically significant pulmonary stenosis between January 2004 and July 2024. Outcomes included significant restenosis, moderate-or-greater pulmonary regurgitation, pulmonary valve reintervention, and surgical reintervention. Time-to-event outcomes and predictors were assessed using Kaplan–Meier estimates and Cox regression. Results: A total of 129 patients were included (median age 1.5 months; 37.2% with critical pulmonary stenosis). Procedural success was 94.5%. The median right ventricular-to-pulmonary artery gradient decreased from 44 to 7 mmHg ( p < 0.001). During a median 7 years follow-up (interquartile range 3–10), significant restenosis occurred in 25.6%, moderate-or-greater pulmonary regurgitation in 19.4%, and 17.8% underwent pulmonary valve reintervention. Kaplan–Meier analysis demonstrated sustained freedom from adverse outcomes throughout follow-up. Univariable Cox regression identified predilation and a higher balloon-to-annulus ratio as factors associated with an increased hazard of significant restenosis and moderate-or-greater pulmonary regurgitation, whereas a larger pulmonary annulus Z -score was associated with a lower hazard of restenosis. Conclusions: Ballon pulmonary valvuloplasty is a safe and effective first-line therapy in children ≤24 months, providing sustained haemodynamic improvement and durable long-term outcomes. Patients requiring predilation, larger balloon-to-annulus ratios, or having smaller pulmonary annulus Z -scores may benefit from closer long-term echocardiographic surveillance.
- 15 October 2026
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- p. 1-12
Short- and long-term outcomes of balloon pulmonary valvuloplasty in children ≤24 months with critical and haemodynamically significant pulmonary valve stenosis: a 20-year single-centre experience in Medellín, Colombia
Background: Balloon pulmonary valvuloplasty is the treatment of choice for critical and haemodynamically significant pulmonary stenosis, but long-term outcome data in infants, particularly in Latin America, remain limited. We evaluated long-term outcomes and factors associated with adverse outcomes in children ≤24 months. Methods: We retrospectively included consecutive patients ≤24 months who underwent balloon pulmonary valvuloplasty for critical or haemodynamically significant pulmonary stenosis between January 2004 and July 2024. Outcomes included significant restenosis, moderate-or-greater pulmonary regurgitation, pulmonary valve reintervention, and surgical reintervention. Time-to-event outcomes and predictors were assessed using Kaplan–Meier estimates and Cox regression. Results: A total of 129 patients were included (median age 1.5 months; 37.2% with critical pulmonary stenosis). Procedural success was 94.5%. The median right ventricular-to-pulmonary artery gradient decreased from 44 to 7 mmHg ( p < 0.001). During a median 7 years follow-up (interquartile range 3–10), significant restenosis occurred in 25.6%, moderate-or-greater pulmonary regurgitation in 19.4%, and 17.8% underwent pulmonary valve reintervention. Kaplan–Meier analysis demonstrated sustained freedom from adverse outcomes throughout follow-up. Univariable Cox regression identified predilation and a higher balloon-to-annulus ratio as factors associated with an increased hazard of significant restenosis and moderate-or-greater pulmonary regurgitation, whereas a larger pulmonary annulus Z -score was associated with a lower hazard of restenosis. Conclusions: Ballon pulmonary valvuloplasty is a safe and effective first-line therapy in children ≤24 months, providing sustained haemodynamic improvement and durable long-term outcomes. Patients requiring predilation, larger balloon-to-annulus ratios, or having smaller pulmonary annulus Z -scores may benefit from closer long-term echocardiographic surveillance.
- 2 June 2026
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- Vol. 36 (4) , 795-801
Long-term outcomes in adults with repaired tetralogy of Fallot: a single-centre retrospective cohort
Background: Adults with repaired tetralogy of Fallot represent a growing clinical population at risk for long-term cardiovascular complications. Characterising their postoperative course and late outcomes is essential to guide surveillance and management. Objectives: To describe the clinical characteristics and long-term outcomes of adult patients (≥18 years) with repaired tetralogy of Fallot who received care at a quaternary-care institution between January 2000 and December 2024. Methods: We performed a retrospective cohort study. Adult patients with a diagnosis of repaired tetralogy of Fallot who had undergone complete surgical repair either during the study period or before it were included. Clinical and sociodemographic data were obtained.Variables related to prior palliative procedures, type of surgical repair, reinterventions (surgical or catheter-based), and long-term outcomes were analysed. Results: A total of 56 patients were included; 31 (55.4%) were women. The median duration of follow-up after repair was 23 years; twenty patients (35.7%) had undergone a palliative or prior intervention before complete repair. The most common type of outflow tract reconstruction was a transannular patch (37.5%), followed by homograft implantation (25.0%). Reinterventions occurred in 29 patients (51.8%), most commonly pulmonary valve replacement (23 patients, 41.0%), mainly due to progressive pulmonary regurgitation and right ventricular dilation. Arrhythmic complications included premature ventricular contractions in 35.7% of patients. Long-term mortality was 3.6%. Conclusions: Adults with repaired tetralogy of Fallot demonstrate high long-term survival; however, late complications are common and frequently require surgical or catheter-based reintervention. These findings underscore the need for lifelong specialised follow-up in adult CHD programmes.
- 2 June 2026
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- Vol. 36 (4) , 795-801
Long-term outcomes in adults with repaired tetralogy of Fallot: a single-centre retrospective cohort
Background: Adults with repaired tetralogy of Fallot represent a growing clinical population at risk for long-term cardiovascular complications. Characterising their postoperative course and late outcomes is essential to guide surveillance and management. Objectives: To describe the clinical characteristics and long-term outcomes of adult patients (≥18 years) with repaired tetralogy of Fallot who received care at a quaternary-care institution between January 2000 and December 2024. Methods: We performed a retrospective cohort study. Adult patients with a diagnosis of repaired tetralogy of Fallot who had undergone complete surgical repair either during the study period or before it were included. Clinical and sociodemographic data were obtained.Variables related to prior palliative procedures, type of surgical repair, reinterventions (surgical or catheter-based), and long-term outcomes were analysed. Results: A total of 56 patients were included; 31 (55.4%) were women. The median duration of follow-up after repair was 23 years; twenty patients (35.7%) had undergone a palliative or prior intervention before complete repair. The most common type of outflow tract reconstruction was a transannular patch (37.5%), followed by homograft implantation (25.0%). Reinterventions occurred in 29 patients (51.8%), most commonly pulmonary valve replacement (23 patients, 41.0%), mainly due to progressive pulmonary regurgitation and right ventricular dilation. Arrhythmic complications included premature ventricular contractions in 35.7% of patients. Long-term mortality was 3.6%. Conclusions: Adults with repaired tetralogy of Fallot demonstrate high long-term survival; however, late complications are common and frequently require surgical or catheter-based reintervention. These findings underscore the need for lifelong specialised follow-up in adult CHD programmes.